MIRA INFORM REPORT
|
Report Date : |
29.04.2013 |
IDENTIFICATION DETAILS
|
Name : |
INVENTIA HEALTHCARE PRIVATE LIMITED |
|
|
|
|
Formerly Known
As : |
ANKUR PHARMACEUTICALS PRIVATE LIMITED THEMIS LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Unit 703 and 704, 7th Floor, Hub Town Solaris, N S Phadke
Marg, Andheri (East), Mumbai-400069, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
27.09.1985 |
|
|
|
|
Com. Reg. No.: |
11-037597 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.78.330
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239MH1985PTC037597 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMT07689D |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCT5371R |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing and Sales of Pharmaceuticals Formulations. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (50) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 5110000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having a satisfactory track record.
There profitability appear to be low during the current year. However, general financial position of the company is strong.
Performance capability seems to be high. Trade relations are reported to be
fair. Business is active. Payments are reported to be regular and as per
commitments. The company can be considered for normal for business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
BBB+ [Long Term] |
|
Rating Explanation |
Moderate degree of safety and moderate credit risk. |
|
Date |
11.02.2013 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY
|
Name : |
Mr. Hitesh Dave |
|
Designation : |
Financial Manager |
LOCATIONS
|
Registered Office : |
Unit 703 and 704, 7th Floor, Hub Town Solaris, N S Phadke
Marg, Andheri (East), Mumbai-400069, Maharashtra, India |
|
Tel. No.: |
Not Available |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office : |
505, VIP Plaza, Veera Industrial Estate, Link Road, Andheri (West),
Mumbai – 400053, Maharashtra, India |
|
Tel. No.: |
91-22-67163000 |
|
Fax No.: |
91-22-67163100 |
|
E-Mail : |
|
|
|
|
|
Factory : |
F1-F1/1, Additional Ambernath, M.I.D.C., Ambernath (East)-
421506, District Thane, |
|
Tel. No.: |
91-251-2625700 |
|
Fax No.: |
91-251-2625800 |
|
|
|
|
Thane Office : |
A-215, Road No. 30, Wagle Industrial Estate, Thane – 400604,
Maharashtra, India |
|
Tel No.: |
91-22-67173600 |
|
Fax No.: |
91-22-67163700 |
|
|
|
|
|
A-131, Road No.23, Therelek Compound, Wagle Industrial
Estate, Thane – 400604, Maharashtra, India |
|
Tel No.: |
91-22-67163400 |
|
Fax No.: |
91-22-67163500 |
DIRECTORS
AS ON 15.06.2012
|
Name : |
Mr. Janak Ramanlal Shah |
|
Designation : |
Managing Director |
|
Address : |
30, Saujanya, Vallabh Nagar Society, N S Road No. 3, JVPD Scheme, Vile
Parle (West), Mumbai-400056, Maharashtra, India |
|
Date of Birth/Age : |
19.11.1947 |
|
Date of Appointment : |
27.09.1985 |
|
Din No.: |
00019819 |
|
|
|
|
Name : |
Mrs. Maya Janak Shah |
|
Designation : |
Director |
|
Address : |
30, Saujanya, Vallabh Nagar Society, N S Road No. 3, JVPD Scheme, Vile
Parle (West), Mumbai-400056, Maharashtra, India |
|
Date of Birth/Age : |
08.04.1950 |
|
Date of Appointment : |
27.09.1985 |
|
Din No.: |
00019904 |
|
|
|
|
Name : |
Mr. Ankur Janak Shah |
|
Designation : |
Nominee Director |
|
Address : |
30, Saujanya, Vallabh Nagar Society, N S Road No. 3, JVPD Scheme, Vile
Parle (West), Mumbai-400056, Maharashtra, India |
|
Date of Birth/Age : |
227.10.1977 |
|
Date of Appointment : |
04.07.2008 |
|
Din No.: |
01656781 |
|
|
|
|
Name : |
Mr. Bharat Bakhshi |
|
Designation : |
Nominee Director |
|
Address : |
C-6, Meghdoot, 536 Linking Road, Khar, Mumbai-400052, Maharashtra,
India |
|
Date of Birth/Age : |
05.09.1968 |
|
Date of Appointment : |
04.07.2008 |
|
Din No.: |
01381524 |
|
|
|
|
Name : |
Mr. Prabuddha Ganguli |
|
Designation : |
Independent Director |
|
Address : |
201, Sunview Heights, 262, Sher E Punjab, Andheri (East),
Mumbai-400093, Maharashtra, India |
|
Date of Birth/Age : |
23.06.1948 |
|
Date of Appointment : |
04.06.2010 |
|
Din No.: |
03091961 |
KEY EXECUTIVES
|
Name : |
Ms. Rupa D. Desai |
|
Designation : |
Company Secretary |
|
Address : |
Flat No. 1, Archana CHS Tagore Road, Santacruz (West), Mumbai-400054,
Maharashtra, India |
|
Date of Birth/Age : |
02.04.1972 |
|
Date of Appointment : |
19.07.2010 |
|
Pan No.: |
ADKPR1935N |
|
|
|
|
Name : |
Mr. Hitesh Dave |
|
Designation : |
Financial Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 15.06.2012
|
Names of Shareholders |
|
No. of Shares |
|
Janak Ramanlal Shah |
|
3254350 |
|
Maya Janak Shah |
|
2720650 |
|
Vishal Janak Shah |
|
12000 |
|
Gaurang Hasmukhlal Thanawala |
|
100 |
|
Daksha Gaurang Thanawala |
|
100 |
|
Sachi Gaurang Thanawala |
|
100 |
|
Dwiti Gaurang Thanawala |
|
100 |
|
Varun Gaurang Thanawala |
|
100 |
|
Nylim Jacob Ballas India Fund III LLC, Mauritius |
|
1833000 |
|
Ankur J Shah |
|
12500 |
|
|
|
|
|
TOTAL
|
|
7833000 |
AS ON 15.06.2012
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others] |
|
23.40 |
|
Directors
or relatives of directors |
|
76.60 |
|
TOTAL |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and Sales of Pharmaceuticals Formulations. |
PRODUCTION STATUS [AS ON 31.03.2011]
|
Particulars |
Unit |
Installed
Capacity * |
Actual
Production |
|
Capsules |
Nos (Millions) |
400 |
145.57 |
|
Tablets |
Nos (Millions) |
600 |
347.50 |
|
Pellets & Granules |
MT |
800 |
352.59 |
NOTE: * As certified by the Management and relied upon by the Auditors being
technical matter.
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|||||||||||||||
|
|
|
|||||||||||||||
|
Bankers : |
|
|||||||||||||||
|
|
|
|||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
S.R. Batliboi and Associates Chartered Accountants |
|
Address : |
14th Floor, The Ruby, 29, Senapati Bapat Marg, Dadar
(West), Mumbai-400028, Maharashtra, India |
|
PAN No: |
AABFS3421N |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000000 |
Equity Shares |
Rs.10/- each |
Rs.100.000 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
7833000 |
Equity Shares |
Rs.10/- each
|
Rs.78.330
Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
78.330 |
78.330 |
78.330 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1199.550 |
1196.142 |
1207.444 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
1277.880 |
1274.472 |
1285.774 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
206.935 |
171.071 |
212.386 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
206.935 |
171.071 |
212.386 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
49.749 |
|
|
|
|
|
|
|
|
TOTAL |
1484.815 |
1445.543 |
1547.909 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1186.231 |
1185.708 |
1227.380 |
|
|
Capital work-in-progress |
87.218 |
67.747 |
17.378 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.025 |
0.025 |
0.025 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
160.403
|
152.964 |
167.738 |
|
|
Sundry Debtors |
195.873
|
167.271 |
186.866 |
|
|
Cash & Bank Balances |
4.668
|
25.845 |
11.732 |
|
|
Other Current Assets |
0.088
|
1.871 |
195.765 |
|
|
Loans & Advances |
84.106
|
137.039 |
95.785 |
|
Total
Current Assets |
445.138
|
484.990 |
657.886 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
166.935
|
180.815 |
117.695 |
|
|
Other Current Liabilities |
57.873
|
99.137 |
215.531 |
|
|
Provisions |
8.989
|
12.975 |
21.534 |
|
Total
Current Liabilities |
233.797
|
292.927 |
354.760 |
|
|
Net Current Assets |
211.341
|
192.063 |
303.126 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
1484.815 |
1445.543 |
1547.909 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
|
|
1174.230 |
|
|
|
Other Income |
|
|
NA |
|
|
|
TOTAL REVENUE (GROSS) |
1438.587 |
1350.522 |
NA |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
TOTAL |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
99.155 |
31.355 |
124.062 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
94.955 |
90.637 |
85.007 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX |
4.200 |
(59.282) |
39.055 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
0.793 |
(47.980) |
3.773 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX |
3.407 |
(11.302) |
35.282 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
173.540 |
184.842 |
165.760 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
0.000 |
0.000 |
2.500 |
|
|
|
Proposed Dividend |
0.000 |
0.000 |
11.749 |
|
|
|
Corporate Dividend Tax |
0.000 |
0.000 |
1.951 |
|
|
BALANCE CARRIED
TO THE B/S |
176.947 |
173.540 |
184.842 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
315.349 |
254.113 |
NA |
|
|
|
Other Earnings |
4.183 |
0.311 |
NA |
|
|
TOTAL EARNINGS |
319.532 |
254.424 |
NA |
|
|
|
|
|
|
|
|
|
|
Earnings /
(Loss) Per Share (Rs.) |
0.43 |
(1.44) |
-- |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
NA |
3.33 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
0.25
|
(3.55) |
2.07 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.00
|
(0.05) |
0.03 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.34
|
0.36 |
0.44 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.90
|
1.65 |
1.85 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by
Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
-- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm / promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
PAN of Proprietor/Partner/Director, if available |
No |
|
32] |
Date
of Birth of Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
Yes |
NOTE:
The registered office of the company has been shifted from Unit S-4, Khira Industrial Premises Cooperative Society Limited, B M Bhargava Road, Santacruz (West), Mumbai-400054, Maharashtra, India to the present address w.e.f. 01.12.2012
BUSINESS DEVELOPMENT, OPERATIONS AND OUTLOOK:
REGULATED MARKETS:
During the year,
the company received marketing approval for Metformin Hcl XR tablets. The
company also filed one more ANDA in the year for Venlafexine Hcl ER capsule.
This brings the total number of ANDA’s filed to date to three, which would
bring in additional revenues in the form of milestone payments in the next
year. During the year, the Company entered into definitive arrangements for two
more ANDAs with a leading US generic company for which the Company received
milestone payments totaling 150,000 USD. The Company also received approval
from UKMHRA (for Tablet line) and ANVISA for the manufacturing facility at
Ambernath. They now have USFDA, UKMHRA, ANVISA and KFDA approvals for their
manufacturing facility.
The company plans
to file five additional ANDA’s during the next year. The Company has already
started work on a new set of projects for the next year for US, Europe and
Brazil. Business arrangements with reputed Pharma companies are under progress
for these new projects.
DOMESTIC MARKETS:
The Company
achieved a marginal growth in domestic sales mainly on account of introduction
of 5 new products in India in last two quarters of 2011-2012. During the year
the Company was able to add 4 new clients for their range of products. The
Company is focused on expediting regulatory approvals for new products in the
pipeline for next year. The plan for next year is to get 7 new products
registered and target a growth of ~22% compared to the current year.
EXPORTS:
The Company
achieved an increase of 25% in export sales amounting to Rs 341.400 Millions as
compared to Rs. 272.600 Millions during the previous year. This growth was
mainly achieved on account of significant growth in Korea, Bangladesh and
Philippines on account of commercialization of previously registered products.
The Company registered forty products during the year and seventeen more
products were commercialized in the international markets of Philippines,
Malaysia, Sri Lanka and Nigeria in 2011-12. Filing of dossiers has also been
initiated in Central America, Caribbean, South America and French West Africa
this year. Commercialization of more products is expected in Latin America and
French West Africa in the next year. Marketing and distribution arrangements in
these countries are currently under progress. The plan is to register same number
of products and commercialize around 25 products next year. They are targeting
approximately 30% increase in export sales for next year which is primarily on
account of more products getting commercialized along with growth of existing
products in these markets.
BANKERS CHARGES
REPORT AS PER REGISTRY
|
This form is for |
Creation of
charge |
|
Corporate
identity number of the company |
INVENTIA
HEALTHCARE PRIVATE LIMITED |
|
Name of the
company |
U24239MH1985PTC037597 |
|
Address of the registered
office or of the principal place of
business in |
Unit S-4, Khira Industrial Premises Cooperative Society
Limited, B M Bhargava Road, Santacruz (West), Mumbai-400054, Maharashtra,
India |
|
Type of charge |
Immovable Property
|
|
Particular of
charge holder |
HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel
(West), Mumbai-400013, Maharashtra, India |
|
Nature of description
of the instrument creating or modifying the charge |
Memorandum of
Equitable mortgage by deposit of title deeds by way of constructive delivery. |
|
Date of
instrument Creating the charge |
25.04.2012 |
|
Amount secured by
the charge |
Rs.100.000
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest As stipulated by
bank from time to time. Terms of Repayment In equated quarterly
installments in 5 years including 6 months moratorium Margin As stipulated by
bank from time to time. Extent and Operation of the charge First exclusive
charge on entire fixed assets of the Company located at Plot No F-1 and
F-1/1, Additional Ambernath, MIDC Area, Ambernath to HDFC Bank Limited
securing additional TL facility of Rs. 100.000 Millions granted to the
company Charge will be valid until all amounts are paid granted to the
Company together with interest, costs, charges and other dues any time
hereafter may become due and owing to the bank in respect of and under the
credit facilities and interest and all the other cost thereto. |
|
Short particulars
of the property charged |
First Exclusive
charge on entire fixed assets of the Company located at Plot No F-1 and
F-1/1, Additional Ambernath, MIDC Area, Ambernath |
FIXED ASSETS:
- Leasehold
Land
- Plant and
Machinery
- Office
Equipments
- Vehicles
- Building
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.29 |
|
|
1 |
Rs.83.88 |
|
Euro |
1 |
Rs.70.67 |
INFORMATION DETAILS
|
Report Prepared
by : |
TPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
50 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.